Volume 33, Nº 1, January and february 2020
DOI: https://doi.org/10.36660/ijcs.20190003
EDITORIAL
Challenges for Anticoagulation in Atrial Fibrillation
Ana Inês da Costa Bronchtein
Abstract
Atrial fibrillation (AF) is the most prevalent arrhythmia in the world.1 It is considered a current epidemic and one of the main causes of ischemic stroke, usually with severe and debilitating conditions, and is responsible for systemic cardioembolic phenomena, increased number of cases of congestive heart failure (CHF), cognitive impairment related to silent embolic phenomena, and increased overall mortality in affected patients.
Keywords: Atrial Fibrillation; Anticoagulants; Brain Ischemia; Vitamin K; Thromboembolism/ prevention and control.